Pharmacogenomics is the study of genetic differences in enzymes, drug transporters and other proteins associated with drug metabolism, which can affect individual responses to drugs in terms of therapeutic effect as well as adverse effects.
Health assessment tools can help you and your provider better understand and quantify your risk for specific diseases and establish goals and strategies for better health.
The NIH definition of implementation science is the study of “strategies to adopt and integrate evidence-based health interventions and change practice patterns within specific settings.” It answers questions such as, “Why do evidence-based interventions lose effectiveness over time in real-world settings?” and “How do interventions need to be applied to various settings to maintain effectiveness?”
Wireless and mobile technologies provide an opportunity to connect information in the real-world via wearable sensors and, when coupled with fixed sensors embedded in the environment produce continuous streams of data on an individual's biology, psychology, behavior and daily environment.
Cancer is one of the most high profile areas to benefit from genomic medicine. From assessing risk of hereditary cancer to profiling tumors to inform treatment, precision medicine is impacting cancer care.
Next-generation whole-genome sequencing is increasingly being used in the clinical setting, and as costs continue to decline it may become a routine part of health care. Early applications of the technology include solving undiagnosed genetic diseases, which may present as diagnostic dilemmas usually in children, or in the neonatal setting.